About cTRL Therapeutics
cTRL Therapeutics is a company based in San Francisco (United States) founded in 2022 by Shana Kelley.. cTRL Therapeutics has raised $19.14 million across 2 funding rounds from investors including Intermountain Healthcare, FACIT and General Catalyst. cTRL Therapeutics offers products and services including cTRL-based Therapy and IsoQore™ Platform. cTRL Therapeutics operates in a competitive market with competitors including Senti Biosciences, Caribou Biosciences, Sana Biotechnology, Poseida Therapeutics and Immunocore, among others.
- Headquarter San Francisco, United States
- Founders Shana Kelley
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.14 M (USD)
in 2 rounds
-
Latest Funding Round
$9.14 M (USD), Seed
Oct 10, 2024
-
Investors
Intermountain Healthcare
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of cTRL Therapeutics
cTRL Therapeutics offers a comprehensive portfolio of products and services, including cTRL-based Therapy and IsoQore™ Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops polyclonal therapies using circulating T cells for solid tumors
Proprietary system for extracting tumor-reactive cells from blood
Funding Insights of cTRL Therapeutics
cTRL Therapeutics has successfully raised a total of $19.14M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $9.14 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $9.1M
-
First Round
First Round
(10 Apr 2023)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Seed - cTRL Therapeutics | Valuation |
investors |
|
| Apr, 2023 | Amount | Seed - cTRL Therapeutics | Valuation | General Catalyst |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in cTRL Therapeutics
cTRL Therapeutics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Intermountain Healthcare, FACIT and General Catalyst. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Founded Year | Domain | Location | |
|
Invests in oncology startups, scales ventures, and drives clinical trials in Ontario.
|
Founded Year | Domain | Location | |
|
Healthcare services are delivered through integrated hospital networks.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by cTRL Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - cTRL Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ctrl Therapeutics Comparisons
Competitors of cTRL Therapeutics
cTRL Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Caribou Biosciences, Sana Biotechnology, Poseida Therapeutics and Immunocore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ctrl Therapeutics
Frequently Asked Questions about cTRL Therapeutics
When was cTRL Therapeutics founded?
cTRL Therapeutics was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is cTRL Therapeutics located?
cTRL Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of cTRL Therapeutics?
Derrell Porter is the current CEO of cTRL Therapeutics.
Is cTRL Therapeutics a funded company?
cTRL Therapeutics is a funded company, having raised a total of $19.14M across 2 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Apr 10, 2023.
What does cTRL Therapeutics do?
cTRL Therapeutics was founded in 2022 in San Francisco, United States, within the biotechnology sector. Focus is placed on developing cell therapies for solid tumors. Magnetic-based technology is utilized to target and activate cTRLs, a rare circulating T cell population in the blood, enabling engineered treatments against cancer. Operations center on enhancing therapeutic access for patients through this specialized approach.
Who are the top competitors of cTRL Therapeutics?
cTRL Therapeutics's top competitors include Immunocore, Juno Therapeutics and Janux Therapeutics.
What products or services does cTRL Therapeutics offer?
cTRL Therapeutics offers cTRL-based Therapy and IsoQore™ Platform.
Who are cTRL Therapeutics's investors?
cTRL Therapeutics has 4 investors. Key investors include Intermountain Healthcare, FACIT, General Catalyst, and FACIT.